October 2018 Volume 14, Issue 10

Volume 14, Issue 10 | October 2018

October 2018

In this Issue

Discovery

Drug Discovery News Placeholder Image

A new answer for amoeba treatment

Skaggs researchers from UCSD repurpose approved drugs to treat fatal brain infection
Drug Discovery News Placeholder Image

Say yes to YRSACT

Scripps scientists find new lead to combat low platelet counts
Drug Discovery News Placeholder Image

Infectious disease research reaches across borders

New collaboration announced between Boehringer Ingelheim and Tsinghua University
Drug Discovery News Placeholder Image

Getting together

A roundup of recent discovery-related deals and agreements
Drug Discovery News Placeholder Image

AI, drug discovery and rare disease

Pharma executive Kate Hilyard joins Healx to drive integration effort forward

Research & Development

Drug Discovery News Placeholder Image

Transcription factors and TransSyn

Multicenter European team reveals computational method for predicting how to convert subpopulations of cells
Drug Discovery News Placeholder Image

All in the epigenetics

Team finds epigenetic reason for drug resistance in deadly melanoma and identifies potential ways to counteract it
Drug Discovery News Placeholder Image

Bispecific boon

Aptevo will use Genedata platform to streamline cancer immunotherapy R&D
Drug Discovery News Placeholder Image

More than just skin

Otezla post-hoc sub-analyses showed meaningful improvements in metrics beyond skin clearance
Drug Discovery News Placeholder Image

Welcome to the real world

PAREXEL and Datavant partner to enhance drug development and commercialization

Special Reports

Drug Discovery News Placeholder Image

Special Report on Cell Biology: Well CHOsen?

Ever more complicated biologics push technical boundaries

Editor's Focus

Drug Discovery News Placeholder Image

Editor’s focus: The struggle against schizophrenia

Therapeutics for mental illness have always been tricky, but schizophrenia seems a bit more intractable than most

Commentary

Drug Discovery News Placeholder Image

New recruits for 2019

Opportunities for Ph.D. students entering the workforce go beyond just academia
Drug Discovery News Placeholder Image

Guest Commentary: Bringing precision medicine to the evaluation and treatment of mental illness

What we do know about the genetics, neurobiology and behavioral science of mental illness can be used to improve diagnosis and treatment

Feature

Drug Discovery News Placeholder Image

Society for Neuroscience Annual Meeting Show Preview: Taking notice of the neurological

SfN annual meeting gets ready for networking, the most recent neurological research and the newest neuroscience
Drug Discovery News Placeholder Image

Focus Feature on Breast Cancer

Beginning with a story about Salk researchers finding a ‘master control switch' for aggressive breast cancer, we give you a quick roundup of recent breast cancer news in honor of Breast Cancer Awareness Month

Preclinical

Drug Discovery News Placeholder Image

Possibility grows for pan-Ebola vaccine

Scripps team discovers potential target mechanisms that could enable the treatment of multiple strains of Ebolavirus
Drug Discovery News Placeholder Image

More coverage on Coversin

Akari reports on the effects of its bimodal Coversin in inflammatory indications
Drug Discovery News Placeholder Image

FR104 offers control of graft-versus-host disease

OSE Immunotherapeutics’ study of the CD28 antagonist was published in Journal of Clinical Investigation
Drug Discovery News Placeholder Image

Peering into the preclinical realm

A roundup of recent preclinical data presentations and journal publications

Clinical Trials

Drug Discovery News Placeholder Image

Effective option for the skin

Clinical trial shows monoclonal antibody drug effective against pruritus
Drug Discovery News Placeholder Image

Dupixent delivers strong Phase 3 results

Patients saw improvements in skin clearing and quality of life
Drug Discovery News Placeholder Image

Out of the starting gate

A roundup of clinical trial startups and initial breakthroughs

Diagnostics

Drug Discovery News Placeholder Image

Diagenode snaps up NXT-Dx

The transaction expands Diagenode’s epigenetics and epigenomics offerings
Drug Discovery News Placeholder Image

‘A clear benefit’

Agena, PerkinElmer partnership emphasizes quality, speed and sensitivity in liquid biopsy
Drug Discovery News Placeholder Image

It’s all in the volume measurement

Data show Daxor’s BVA-100 is superior to formula-based estimates of blood volume in assessing heart failure patients
Drug Discovery News Placeholder Image

A ‘breakthrough biomarker’ for rheumatoid arthritis

Novel test now available to aid in detection and management of debilitating condition

Contract Services

Drug Discovery News Placeholder Image

Partnering for efficiency

Companies collaborate on cloud-based IT validation software for life sciences
Drug Discovery News Placeholder Image

Building better models

CrownBio licenses translational breast cancer models of resistance and metastasis
Drug Discovery News Placeholder Image

Extending the value

CRO announces $7.8M extension agreement for OmniComm’s TrialOne

Business & Government Policy

Drug Discovery News Placeholder Image

Boehringer Ingelheim acquires all ViraTherapeutics shares

The German company seeks to develop next-generation viral-based immuno-oncology therapies
Drug Discovery News Placeholder Image

BIA Separations expands

New lab processing facility will support integrated optimization of upstream and downstream process development
Drug Discovery News Placeholder Image

On the cutting edge

A roundup of instrumentation, software and other tools and technology news
Drug Discovery News Placeholder Image

VistaGen acquires worldwide license of phase 3-ready CNS drug

Candidate from Pherin Pharmaceuticals is meant for as-needed treatment of social anxiety disorder
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue